Published in FEBS Lett on September 01, 2000
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest (2004) 11.05
The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest (2002) 7.90
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A (2001) 5.77
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A (2002) 4.64
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest (2007) 4.09
Forging a field: the golden age of iron biology. Blood (2008) 3.83
Hepcidin and iron regulation, 10 years later. Blood (2011) 3.80
Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A (2005) 3.11
Iron in infection and immunity. Cell Host Microbe (2013) 2.77
The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest (2011) 2.30
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest (2010) 2.18
Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood (2005) 2.08
Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood (2008) 2.01
Mechanisms of anemia in CKD. J Am Soc Nephrol (2012) 1.91
TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood (2006) 1.74
Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal (2008) 1.73
Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A (2001) 1.71
The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood (2005) 1.60
Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med (2007) 1.59
Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood (2009) 1.55
Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology (2009) 1.51
Mechanisms of mammalian iron homeostasis. Biochemistry (2012) 1.51
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo) (2011) 1.50
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice. J Clin Invest (2013) 1.44
Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis (2010) 1.43
Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis (2006) 1.43
Iron homeostasis and the inflammatory response. Annu Rev Nutr (2010) 1.40
The long history of iron in the Universe and in health and disease. Biochim Biophys Acta (2011) 1.33
The role of antimicrobial peptides at the ocular surface. Ophthalmic Res (2008) 1.32
Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica (2009) 1.32
Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest Ophthalmol Vis Sci (2011) 1.32
Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res (2007) 1.28
Ferroportin1 is required for normal iron cycling in zebrafish. J Clin Invest (2005) 1.27
The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood (2013) 1.26
Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem (2009) 1.26
Human antimicrobial peptides and proteins. Pharmaceuticals (Basel) (2014) 1.23
First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut (2005) 1.22
Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. Eur J Appl Physiol (2008) 1.21
Iron regulation by hepcidin. J Clin Invest (2013) 1.21
Neogenin interacts with hemojuvelin through its two membrane-proximal fibronectin type III domains. Biochemistry (2008) 1.20
Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia. Hematol Oncol Clin North Am (2010) 1.14
HJV and HFE Play Distinct Roles in Regulating Hepcidin. Antioxid Redox Signal (2015) 1.10
Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors. PLoS One (2009) 1.10
Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut (2004) 1.10
Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys. AAPS J (2010) 1.10
Iron, anemia and hepcidin in malaria. Front Pharmacol (2014) 1.10
Liver iron transport. World J Gastroenterol (2007) 1.08
Implications of malaria on iron deficiency control strategies. Adv Nutr (2012) 1.07
Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis. Genet Med (2010) 1.07
Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis (2008) 1.07
Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One (2012) 1.06
Role of alcohol in the regulation of iron metabolism. World J Gastroenterol (2007) 1.06
Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation. Am J Physiol Gastrointest Liver Physiol (2006) 1.06
Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res (2007) 1.06
A novel immunological assay for hepcidin quantification in human serum. PLoS One (2009) 1.05
Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Front Pharmacol (2014) 1.04
Iron and the immune system. J Neural Transm (Vienna) (2010) 1.03
Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe (2015) 1.03
Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect Microbiol (2014) 1.03
Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis. J Biol Chem (2011) 1.03
A general map of iron metabolism and tissue-specific subnetworks. Mol Biosyst (2009) 1.02
Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf (2004) 1.00
Exercise as a mediator of hepcidin activity in athletes. Eur J Appl Physiol (2010) 0.99
Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta (2010) 0.99
Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut (2006) 0.98
The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes. J Clin Transl Endocrinol (2014) 0.98
beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload. Adv Hematol (2010) 0.98
Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha. Am J Pathol (2007) 0.96
Sequestration and scavenging of iron in infection. Infect Immun (2013) 0.95
Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. Arthritis Res Ther (2013) 0.95
Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling. Am J Physiol Cell Physiol (2011) 0.95
Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer. J Cancer Res Clin Oncol (2006) 0.95
Hepcidin: the missing link between hemochromatosis and infections. Infect Immun (2003) 0.94
Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology (2008) 0.94
Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus. PLoS One (2012) 0.94
Retinal iron homeostasis in health and disease. Front Aging Neurosci (2013) 0.94
Increased duodenal iron uptake and transfer in a rat model of chronic hypoxia is accompanied by reduced hepcidin expression. Gut (2005) 0.94
The role of intravenous iron in the treatment of anemia in cancer patients. Ther Adv Hematol (2012) 0.93
The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients. Nephrol Dial Transplant (2013) 0.93
Iron homeostasis in osteoporosis and its clinical implications. Osteoporos Int (2012) 0.93
Iron metabolism: current facts and future directions. Biochem Med (Zagreb) (2012) 0.92
Activated macrophages induce hepcidin expression in HuH7 hepatoma cells. Haematologica (2009) 0.92
Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease? World J Gastroenterol (2009) 0.92
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis. Haematologica (2014) 0.92
Antimicrobial functionalized genetically engineered spider silk. Biomaterials (2011) 0.91
Hepcidin regulation by BMP signaling in macrophages is lipopolysaccharide dependent. PLoS One (2012) 0.91
Bacterial cell wall constituents induce hepcidin expression in macrophages through MyD88 signaling. Inflammation (2012) 0.91
Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus. Front Cell Neurosci (2012) 0.90
Exploring Staphylococcus aureus pathways to disease for vaccine development. Semin Immunopathol (2011) 0.90
Hepcidin and Host Defense against Infectious Diseases. PLoS Pathog (2015) 0.89
Hepcidin and iron status among pregnant women in Bangladesh. Asia Pac J Clin Nutr (2008) 0.89
Hepcidin expression in human airway epithelial cells is regulated by interferon-γ. Respir Res (2011) 0.88
Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. Protein Sci (2003) 0.88
Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload. Hum Genet (2004) 0.88
Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study. Crit Care (2011) 0.88
Recent advances in understanding haemochromatosis: a transition state. J Med Genet (2004) 0.88
The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease. Acta Neuropathol Commun (2013) 0.88
Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans. PLoS One (2016) 0.87
Hepcidin: regulation of the master iron regulator. Biosci Rep (2015) 0.87
Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell (2001) 4.36
hBD-1: a novel beta-defensin from human plasma. FEBS Lett (1995) 3.79
Health education and community empowerment: conceptualizing and measuring perceptions of individual, organizational, and community control. Health Educ Q (1994) 3.69
Macromolecular trafficking indicated by localization and turnover of sucrose transporters in enucleate sieve elements. Science (1997) 3.43
Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J (2001) 2.52
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
A study of the T system in rat heart. J Cell Biol (1970) 2.20
Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet (2000) 2.04
SUT2, a putative sucrose sensor in sieve elements. Plant Cell (2000) 1.97
Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett (2003) 1.70
Retracted The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg (2001) 1.63
Guanylin strongly stimulates rat duodenal HCO3- secretion: proposed mechanism and comparison with other secretagogues. Gastroenterology (1996) 1.53
Challenges in planning and conducting diagnostic studies with molecular biomarkers. Dtsch Med Wochenschr (2013) 1.53
Origin of a chloroplast protein importer. Proc Natl Acad Sci U S A (1998) 1.51
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology (2000) 1.50
Hepatoblastoma in a child with progressive familial intrahepatic cholestasis. Pediatr Transplant (2005) 1.48
Translocation of structural P proteins in the phloem. Plant Cell (1999) 1.45
An electron microscope study of the perfusion-fixed spleen. 1. The splenic circulation and the RES concept. Z Zellforsch Mikrosk Anat (1969) 1.45
Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes. Virology (1981) 1.43
Molecular organization of the Escherichia coli gab cluster: nucleotide sequence of the structural genes gabD and gabP and expression of the GABA permease gene. Arch Microbiol (1993) 1.38
Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation. Bone Marrow Transplant (2010) 1.38
Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology (2004) 1.36
New fluorescent dyes in the red region for biodiagnostics. J Fluoresc (1995) 1.35
Enterochromaffin cells of the digestive system: cellular source of guanylin, a guanylate cyclase-activating peptide. Proc Natl Acad Sci U S A (1994) 1.33
Processing of sound sequences in macaque auditory cortex: response enhancement. J Neurophysiol (1999) 1.31
[Studies on the ultrastructure of rat heart muscle with special attention to the sarcoplasmic reticulum]. Z Zellforsch Mikrosk Anat (1966) 1.30
Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci (2001) 1.29
Long-distance phloem transport of glucosinolates in Arabidopsis. Plant Physiol (2001) 1.28
LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem (1999) 1.28
Small cell neuroendocrine (oat cell) carcinoma of the male breast. Immunocytochemical and ultrastructural investigations. Virchows Arch A Pathol Anat Histopathol (1984) 1.26
Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia (2007) 1.25
Myoendothelial contacts in glomerular arterioles and in renal interlobular arteries of rat, mouse and Tupaia belangeri. Cell Tissue Res (1984) 1.24
Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily. Protein Sci (1999) 1.23
An improved perfusion fixation method for the testis. Anat Rec (1977) 1.22
Morphological alterations and functional changes of interhepatocellular junctions induced by bile duct ligation. Cell Tissue Res (1977) 1.21
V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms. Hum Mutat (1998) 1.21
Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology (1997) 1.20
Distribution of vasoactive intestinal polypeptide-like immunoreactivity in the mammalian heart. Interrelation with neurotensin- and substance P-like immunoreactive nerves. Cell Tissue Res (1984) 1.20
Structural evidence for glucagon producing cells in the intestinal mucosa of the rat. Diabetologia (1968) 1.18
Single molecule DNA sequencing in submicrometer channels: state of the art and future prospects. J Biotechnol (2001) 1.17
Isolation and characterization of the circulating form of human endostatin. FEBS Lett (1997) 1.16
Overproduction of 5-enolpyruvylshikimate-3-phosphate synthase in a glyphosate-tolerant Petunia hybrida cell line. Arch Biochem Biophys (1986) 1.16
Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J Clin Invest (2000) 1.15
The endocrine cells in the epithelium of the gastrointestinal mucosa of the rat. An electron microscope study. J Cell Biol (1969) 1.15
Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr (1988) 1.14
Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res (1998) 1.13
HCC-1, a novel chemokine from human plasma. J Exp Med (1996) 1.13
HCC-2, a human chemokine: gene structure, expression pattern, and biological activity. Proc Natl Acad Sci U S A (1998) 1.12
Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia. Am J Trop Med Hyg (1999) 1.11
Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism. Immunobiology (1986) 1.09
Peptidomics technologies for human body fluids. Trends Biotechnol (2001) 1.09
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J Exp Med (2000) 1.08
hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol (2005) 1.07
Luteolin protects rat PC12 and C6 cells against MPP+ induced toxicity via an ERK dependent Keap1-Nrf2-ARE pathway. J Neural Transm Suppl (2007) 1.07
The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. Rev Physiol Biochem Pharmacol (2002) 1.06
Intrinsic human glomerular mesangial cells can express receptors for IgG complexes (hFc gamma RIII-A) and the associated Fc epsilon RI gamma-chain. J Immunol (1994) 1.05
Association states of the transcription activator protein NtrC from E. coli determined by analytical ultracentrifugation. J Mol Biol (1998) 1.05
Tuber physiology and properties of starch from tubers of transgenic potato plants with altered plastidic adenylate transporter activity. Plant Physiol (2001) 1.05
Solution structure of a naturally-occurring zinc-peptide complex demonstrates that the N-terminal zinc-binding module of the Lasp-1 LIM domain is an independent folding unit. Biochemistry (1996) 1.04
Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat. Neurosci Lett (1984) 1.04
Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J Clin Endocrinol Metab (2000) 1.04
The similarities of bar and pat gene products make them equally applicable for plant engineers. Nat Biotechnol (1996) 1.04
Osteonectin--a differentiation marker of bone cells. Cell Tissue Res (1987) 1.04
Localization of neurotensin-immunoreactive cells in the small intestine of man and various mammals. Histochemistry (1977) 1.03
The circulating bioactive form of human guanylin is a high molecular weight peptide (10.3 kDa). FEBS Lett (1993) 1.03
Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15. J Leukoc Biol (2001) 1.02
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G. Oncogene (1998) 1.02
Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatr (1998) 1.02
Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr B Biomed Sci Appl (1999) 1.02
Unusual differentiation of a combination tumor of the parotid gland. A case report. Pathol Res Pract (1993) 1.02
Identification and isolation of glucose dehydrogenase genes of Bacillus megaterium M1286 and their expression in Escherichia coli. Eur J Biochem (1988) 1.02
Vacuoles release sucrose via tonoplast-localised SUC4-type transporters. Plant Biol (Stuttg) (2011) 1.01
Overexpression of phosphatidylinositol 3-kinase in human lung cancer. Langenbecks Arch Surg (2001) 1.01
Molecular analysis and clinical aspects of four patients with Chédiak-Higashi syndrome (CHS). Clin Genet (2007) 1.01
Casocidin-I: a casein-alpha s2 derived peptide exhibits antibacterial activity. FEBS Lett (1995) 1.00
Hepatocyte innervation in primates. J Cell Biol (1977) 0.99
Membrane topology of the 22 kDa integral peroxisomal membrane protein. FEBS Lett (1993) 0.99
Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol (1994) 0.98